Citrate during Donor Plasmapheresis

被引:0
|
作者
Evers, J. [1 ]
Taborski, U. [1 ]
机构
[1] Octapharma Plasma & Plasmazentrum Aachen, Helleter Feldchen 9, D-52146 Aachen, Germany
关键词
apheresis; citrate; citrate infusion rate; citrate toxicity; plasmapheresis;
D O I
10.1055/s-0042-100560
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe the distribution of trisodium-citrate 4% anticoagulant between the product and the donors undergoing plasma donation. The paper is based upon data of 32 regular donors of plasma initially collected for a study published in 2010 [1]. These data were re-analysed to determine the amount of citrate received by the donor and the citrate infusion rate in mg/kg/min to the donor [2]. Donor plasmaphereses were performed with the automated Haemonetics r PCS2. 130 +/- 12 ml trisodium-citrate 4% was used for 760ml plasma. An average of 110 ml trisodiumcitrate 4% was in collected plasma and not given to the donor. From the difference of 20 ml trisodium- citrate 4% an average citrate infusion rate of 0.16 mg/kg/min was calculated. It was concluded that the total amount of citrate anion received by the donor is only 514 mg and that the average citrate infusion rate of 0.16mg/kg/min is very low [2].
引用
收藏
页码:23 / 25
页数:3
相关论文
共 50 条
  • [21] Feasibility, Efficacy, and Safety of Peripheral Venous Access for Chronic Double-Filtration Plasmapheresis with Regional Citrate Anticoagulation
    Cardinale, Antoine
    Pambrun, Emilie
    Prelipcean, Camelia
    Messikh, Ziyad
    Moranne, Olivier
    BLOOD PURIFICATION, 2023, 52 (7-8) : 621 - 630
  • [22] Ischemic Stroke After Plasmapheresis
    Salahuddin, Hisham
    Sheikh, Ajaz Ahmad
    Hussaini, Sharmeen
    Verghese, Cherian
    Tietjen, Gretchen E.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2018, 356 (04) : 399 - 403
  • [23] Plasmapheresis in immunologically mediated polyneuropathies
    Kiprov, DD
    Hofmann, JC
    THERAPEUTIC APHERESIS AND DIALYSIS, 2003, 7 (02) : 189 - 196
  • [24] Utility of plasmapheresis in intensive care
    Salazar Ramirez, C.
    Daga Ruiz, D.
    Cota Delgado, F.
    Fernandez Aguirre, C.
    Fernandez Anon, J. M.
    Garcia Fernandez, J. M.
    MEDICINA INTENSIVA, 2010, 34 (01) : 74 - 78
  • [25] Plasmapheresis in a patient with antiphospholipid syndrome before living-donor kidney transplantation: a case report
    Sofue, Tadashi
    Hayashida, Yushi
    Hara, Taiga
    Kawakami, Kazuyo
    Ueda, Nobufumi
    Kushida, Yoshio
    Inui, Masashi
    Dobashi, Hiroaki
    Kakehi, Yoshiyuki
    Kohno, Masakazu
    BMC NEPHROLOGY, 2014, 15
  • [26] Plasmapheresis in a patient with antiphospholipid syndrome before living-donor kidney transplantation: a case report
    Tadashi Sofue
    Yushi Hayashida
    Taiga Hara
    Kazuyo Kawakami
    Nobufumi Ueda
    Yoshio Kushida
    Masashi Inui
    Hiroaki Dobashi
    Yoshiyuki Kakehi
    Masakazu Kohno
    BMC Nephrology, 15
  • [27] Minimising changes in plasma calcium and magnesium concentrations during plasmapheresis
    Rajesh G. Krishnan
    Malcolm G. Coulthard
    Pediatric Nephrology, 2007, 22 : 1763 - 1766
  • [28] Minimising changes in plasma calcium and magnesium concentrations during plasmapheresis
    Krishnan, Rajesh G.
    Coulthard, Malcolm G.
    PEDIATRIC NEPHROLOGY, 2007, 22 (10) : 1763 - 1766
  • [29] An Unfortunate Case of Takotsubo Cardiomyopathy During Plasmapheresis for Myasthenia Crisis
    Jahangir, Abdullah
    Niazi, Muhammad Rafay Khan
    Sahra, Syeda
    Javed, Aneeqa
    Krzyzak, Michael
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [30] plasmapheresis
    Oral, Mehmet
    Yilmaz, Ali Abbas
    JOURNAL OF THE TURKISH SOCIETY OF INTENSIVE CARE-TURK YOGUN BAKM DERNEGI DERGISI, 2008, 6 (01): : 19 - 24